beta-catenin expression in benign and malignant pilomatrix neoplasms
Authors:
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 150 (3) , 511-516
Abstract
Beta-catenin is a 92-kDa protein, initially identified as a coprecipitating species with the E-cadherin cell-cell adhesive complex. It plays a role in signal transduction in the Wnt signalling pathway and has been identified as an oncogene in colon cancer and melanoma. Exon 3 beta-catenin-activating mutations were found in 75% of cases of pilomatricoma (PM). Previous studies have shown that nuclear and/or cytoplasmic staining may correlate with beta-catenin gene mutation. Because the immunohistochemical expression of beta-catenin in the nucleus or the cytoplasm correlates with beta-catenin mutation, we studied the immunohistochemical profile of beta-catenin expression in normal scalp hair follicles and in PM and pilomatrix carcinoma (PC). We reviewed 21 cases of PM and five cases of PC using immunohistochemical staining with commercially available antibody in a standard fashion on formalin-fixed paraffin-embedded tissue samples. All 26 tumours displayed both nuclear and cytoplasmic staining in the basaloid cells with focal membranous staining. Shadow cells were negative in all tumours. Normal control sections from the scalp displayed nuclear reactivity of the matrical cells, mostly concentrated in the supramatrical zone of hair follicles. Membranous staining was present along the intercellular junctions of the epidermis and along the outer and inner root sheaths of hair follicles. We have found similar patterns of beta-catenin nuclear and cytoplasmic expression in both PM and PC. Despite the shared beta-catenin expression, the biological behaviour of PM and PC is markedly different. These two tumours probably share the activation of a common cellular pathway that could be related to their shared method of keratinization or a shared dysfunction of the cellular adhesion complex and consequently tumorigenesis. To the best of our knowledge, this is the first report on the beta-catenin immunohistochemical expression profile in PC.Keywords
This publication has 20 references indexed in Scilit:
- Dynamic expression and nuclear accumulation of β-catenin during the development of hair follicle-derived structuresMechanisms of Development, 2001
- beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair folliclesBritish Journal of Dermatology, 2001
- beta-Catenin expression in the transitional cell zone of pilomatricoma.British Journal of Dermatology, 2001
- β‐Catenin gene mutation in human hair follicle‐related tumorsPathology International, 2001
- Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.Molecular Pathology, 1999
- β-Catenin regulates expression of cyclin D1 in colon carcinoma cellsNature, 1999
- Identification of c- MYC as a Target of the APC PathwayScience, 1998
- Cleaning up on β-cateninNature Medicine, 1997
- Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 1997
- Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate.Genes & Development, 1995